OBJECTIVES: Prior studies have established peak postoperative lactate and the vasoactive-inotrope score (VIS) as modest predictors of outcome following paediatric cardiac surgery. We developed a novel vasoactive-ventilation-renal (VVR) score and aimed to determine if this index, which incorporates postoperative respiratory, cardiovascular and renal function, would more consistently predict outcome in this patient population.
INTRODUCTION
Children undergoing cardiac surgery with cardiopulmonary bypass, especially those with complex forms of congenital heart disease, can require considerable haemodynamic and ventilator support postoperatively during a prolonged recovery period [1] [2] [3] [4] . The postoperative management of these complicated patients is primarily focused on restoring cardiopulmonary homoeostasis and mitigating other end-organ damage associated with postoperative cardiopulmonary dysfunction [5, 6] . To date, the development of indices that accurately reflect the severity of their illness and the degree of required support in this patient population has been challenging.
Most recently, the vasoactive-inotrope score (VIS) and serum lactate have been investigated as a means to this end, and both have been shown to modestly correlate with outcomes [7] [8] [9] . In particular, the VIS quantifies the degree of postoperative pharmacological support required to maintain adequate haemodynamic stability, while serum lactate is representative of end-organ perfusion. Children recovering from cardiac surgery, however, frequently have multiorgan dysfunction, especially with regard to the integrity of the pulmonary and renal systems [10, 11] , and neither the VIS nor serum lactate reflects the function of these organ systems.
To address the limitations of the VIS and serum lactate, we sought to develop a novel scoring system that incorporates postoperative markers of cardiovascular, pulmonary and renal dysfunction, arguably the three most commonly affected organ systems in children after surgery for congenital heart disease (CHD). Additionally, we sought to validate this novel score by examining its association with objective outcome measures that are commonly reported in studies of patients recovering from paediatric cardiac surgery and that would therefore have the broadest applicability among centres. We postulated that this combined score would outperform isolated measures of cardiovascular integrity such as the VIS and serum lactate.
METHODS

Patient population
This retrospective cohort study was approved by the Institutional Review Boards at Wayne State University and the Detroit Medical Center. For this pilot study, we reviewed acyanotic infants <365 days who underwent cardiac surgery with cardiopulmonary bypass from January 2009 to April 2013. Patients with single ventricle physiology and residual right-to-left shunting (e.g. intentionally unrepaired patent foramen ovale) as determined by postoperative transoesophageal echocardiography were excluded. We aimed to first validate this score in patients in which the assessment of their respiratory system function using arterial blood gas measurements would not be obscured by intracardiac shunting. Additionally, patients requiring extracorporeal membrane oxygenation (ECMO) at 48 h of intensive care unit (ICU) admission were also excluded, as their inotrope and ventilator requirements would not have been reflective of their underlying disease severity, but rather of the mechanical support.
Data collection
Pre-and perioperative data collected included: age, height and weight at the time of surgery, gestational age, anatomical diagnosis and procedure performed, associated genetic abnormalities, presence of preoperative mechanical ventilation, cardiopulmonary bypass (CPB) duration, aortic cross-clamp duration, duration of hypothermic circulatory arrest if used, preoperative serum creatinine values and basic and comprehensive Aristotle scores [12] . All arterial blood gas and lactate measurements obtained during the first 48 postoperative hours were recorded (which are performed simultaneously using point-of-care testing), along with the ventilator support at the time of each measurement, which included respiratory rate, fraction of inspired oxygen (FiO 2 ), peak inspiratory pressure (PIP), positive end-expiratory pressure (PEEP) and mean airway pressure (MAP). Doses of inotropic and vasopressor medications (e.g. dopamine, dobutamine, epinephrine, norepinephrine, milrinone and vasopressin) at the time of each arterial blood gas measurement were also recorded. Finally, serum creatinine values obtained on admission, postoperative day 1 and postoperative day 2 were recorded.
Derivation of the vasoactive-ventilation-renal score
From these data, we first calculated each patient's VIS at the time of each postoperative arterial blood gas measurement. The VIS was calculated in the following manner [7] : VIS ¼ dopamine dose ðmg=kg=minÞ þ dobutamine dose ðmg=kg=minÞ þ 100 Â epinephrine dose ðmg=kg=minÞ þ 10 Â milrinone dose ðmg=kg=minÞ þ 10000 Â vasopressin dose ðU=kg=minÞ þ 100 Â norepinephrine dose ðmg=kg=minÞ:
For patients on no vasoactive support at the time of blood gas measurement, VIS = 0. Secondly, we calculated an oxygenation index (OI) and ventilation index (VI), two commonly used measures of pulmonary function in children with respiratory disease [13] [14] [15] , for each postoperative arterial blood gas measurement as follows:
For patients extubated at the time of arterial blood gas measurement, OI and VI = 0. Receiver operating characteristics (ROCs) for all outcome measures and both OI and VI were plotted and areas under the receiver-operating curve (AUC) were calculated. A priori, we planned to use this analysis to determine which of the two respiratory indices would best be suited for inclusion in the final scoring system. The AUCs for these two indices are provided in Table 1 , which identifies VI as a better marker of respiratory disease in these patients. Finally, baseline preoperative serum creatinine was subtracted from each postoperative serum creatinine measurement (e.g. on admission and postoperative days 1 and 2), which we labelled ΔCr. For patients in which postoperative serum creatinine measurements were less than baseline, we recorded ΔCr = 0. We then combined these three markers of end-organ integrity to calculate a combined vasoactive-ventilation-renal score (VVR) at the time of each arterial blood gas measurement:
Based on prior studies examining the predictive value of the VIS alone [7, 8] , we focused our analyses on the admission, peak and 48-h measurements. Primary outcomes of interest included: duration of mechanical ventilation (DMV), defined as the time from ICU admission to first extubation; duration of vasoactive agents (DVAs), defined as the time from ICU admission to the time the last agent used in VIS calculation was discontinued; duration of chest tubes (DCTs), defined as the time from ICU admission to the time the last chest tube was discontinued; paediatric ICU length of stay (PLOS) and hospital length of stay (HLOS). Secondary outcomes included in-hospital mortality and number of ventilator-free days at 28 days postoperatively (to control for patients who died early in their hospital course). 
Statistical analysis
All statistical analysis was performed using SAS version 9.2. Descriptive statistics were used to represent the study population. Data are provided as medians with ranges for continuous variables and absolute counts with percentages for categorical variables. We initially sought to determine whether any relationship existed between the VVR score and outcomes. Data were analysed for correlation using Spearman's rho with bootstrapping. To further characterize the VVR as a postoperative scoring system, all primary outcomes were then dichotomized as upper (worst) 25th percentile versus lower 75th percentile. The AUCs were then calculated for the VVR and VIS at all three time points and for peak serum lactate (during the first 48 postoperative hours) along with all primary outcome variables. Following this analysis, all of the above measures were modelled as a predictor using unconditional logistic regression by use of Harris' SAS macro [16] . The sensitivity, specificity, weighted error ratios and AUCs were then calculated and plotted. The score with the largest AUC was chosen as the best predictor of outcomes. The best cut-off for VVR and VIS was chosen to maximize combined sensitivity and specificity while minimizing the weighted error ratio. Multiple logistic regression modelling was then performed. Demographic and surgical characteristics were assessed between patients with outcomes in the upper 25th percentile versus those patients with outcomes in the lower 75th percentile using the χ 2 test for categorical variables and the t-test, Wilcoxon rank-sum test or analysis of variance, as appropriate, for categorical variables. The characteristics that, on bivariate analysis, were statistically different between the groups (P <0.05) were chosen as potential covariates for regression modelling. These potential covariates were then integrated into the regression model using best subset logistic regression. The results of this analysis was then used to determine the best-fit models for all outcomes by adjusting for only those demographic and surgical characteristics that were found to confound the association between an elevated VVR and prolonged outcomes.
RESULTS
Study population
A total of 222 patients were examined. The patient population included a broad range of surgical complexity including 60 (27.0%) patients within Basic Aristotle Complexity Level 4. A summary of the specific lesions are listed in Table 2 and demographic characteristics of the patient cohort are given in Table 3 . Of note, 5 patients (2.3%) did not survive to discharge. Two of these patients required ECMO prior to 48 h postoperatively and were therefore excluded from all analyses. The 3 additional patients who died were only included in the analysis of ventilatorfree days at 28 days postoperatively, so that their abbreviated durations of mechanical ventilation and ICU stay would not be misrepresented as positive outcomes. Thus, 217 patients were included in the analysis of all primary outcome measures and 220 patients were included in the analysis of ventilator-free days at 28 days postoperatively. The median admission, peak, and 48-h VIS and VVR scores and median peak lactate values are presented in Table 4 , as are ranges and upper 25th percentile cut-offs for all outcome variables. Of note, the VVR score was approximately three times higher than the VIS, which indicates that the VI and change in creatinine were heavily weighted within the score relative to the VIS.
Vasoactive-ventilation-renal score VVR performance relative to vasoactive-inotrope score and lactate Analysis of the Spearman correlation coefficients showed the VVR at all three postoperative time points to be very highly correlated with all outcomes, more so than the corresponding VIS and peak lactate. Correlation coefficients for outcomes and scoring systems are presented in Supplementary material, Table S1 .
Owing to the high correlation between the VVR and outcomes, we then performed receiver operating characteristic (ROC) analysis for admission, peak and 48-h VVR and VIS, and for peak lactate. These variables were modelled as predictors of all outcomes with the exception of ventilator-free days. For all three time points (e.g. admission, peak and 48-h), the VVR performed well and had a greater AUC than the corresponding VIS alone for all outcome measures. Further, of the three VVR measurements, the 48-h VVR (VVR48) had the highest AUC for all outcome measures. The ROC curves for admission VVR, peak VVR and VVR48 and DMV are presented in Fig. 1 . Moreover, AUC for VVR48 and prolonged DMV was 0.935 [95% confidence intervals (CI): 0.900-0.971], the highest AUC among all measured outcomes. In comparison, AUCs for the 48-h VIS (VIS48) and peak lactate and prolonged DMV were considerably lower, as illustrated in Fig. 2 . The AUC values for the VVR, VIS and peak lactate measurements and the remaining outcomes are available in Supplementary material, Table S2 .
To further compare VVR48 to VIS48, we performed best subset multiple logistic regression modelling for both scores. Cut-offs for the predictor variables were chosen to maximize total accuracy and minimize weighted error ratios as previously described by Harris [16] and Lambert et al. [17] . Cut-off values for VVR48 and VIS48 were 22.5 and 9.5, respectively. We also examined peak VVR and VIS and peak lactate to compare with prior studies [7, 8] , for which we obtained cut-off values of 43.4, 14.5 and 3.7, respectively. Potential confounders were assessed among all models. Using the best subset model, it was found that the duration of CPB and aortic cross-clamping improved the fit of the VVR model and duration of CPB alone improved the fit of the VIS model; thus, these variables remained in the respective regression models. No other potential confounders including age, weight, presence of chromosomal abnormalities, preoperative mechanical ventilation, duration of circulatory arrest, use of inhaled nitric oxide or basic and comprehensive Aristotle scores improved the fit of the model and so were not included in the final analysis. The results of the regression analysis are given in Table 5 . High VVR48 (>22.5) was strongly associated with increased odds of prolonged DMV [odds ratio (OR): 39.1, 95% CIs: 14.1-108.8. High VIS48 (OR: 6.2, 95% CIs: 2.9-13.4) was also significantly associated with increased odds of prolonged mechanical ventilation, but much less so than VVR48. High VVR48 was also independently associated with higher odds for prolonged DAVs and chest tube drainage, and was modestly yet significantly associated with prolonged ICU and hospital length of stay. For all outcomes, ORs for VVR48 were greater than the respective ratios for the VIS alone (Table 5) . Additionally, VVR48 scores were more strongly associated with prolonged outcomes than peak VVR.
Peak lactate was significantly, if weakly, associated with all outcomes with the exception of DCT drainage, and significantly less strongly associated with DMV, duration of vasoactive medications and DCT drainage when compared with VVR48. There was a numerical, but not statistical, difference in ORs between these two scores and ICU and hospital length of stay.
As noted previously, 2 of the 5 patients who did not survive to hospital discharge were requiring ECMO support at 48 h and therefore did not have VVR values. Of the remaining 3 patients who died, their VVR48 values were 51.2, 69.3 and 78.2, which represent 3 of the 7 highest VVR48 values calculated.
DISCUSSION
This study is, to our knowledge, the first to develop a multiorgan system disease severity of illness index aimed at children undergoing cardiac surgery. Previous studies have shown that the VIS alone [7, 8] and serum lactate [9] are helpful in predicting outcomes in this patient population. Our findings confirm our hypothesis-by adding measures of respiratory and renal dysfunction to the VIS, we were able to better predict all outcomes in this patient population. Of particular importance, after adjustment for potential confounders, VVR48 was superior to the VIS alone in predicting the DMV, one of the most commonly used outcome measures in paediatric cardiac critical care research. The AUC measurement for VVR48 and mechanical ventilation was also higher than that measured for the VI alone. These findings should be intuitive to clinicians accustomed to caring for this patient population, as their postoperative courses can be complicated by cardiac dysfunction, pulmonary disease, acute kidney injury or a combination of all 3. Indeed, some patients may have considerable post-CPB lung and/or kidney injury with relatively preserved haemodynamic integrity, and for these children, neither the VIS alone nor serum lactate would be representative of their disease burden.
In our study, the VVR48 score was more predictive of all of our primary and secondary outcomes than the VVR measured at peak or at admission to the ICU. This finding is consistent with the results reported by Davidson et al. [8] for the VIS alone. By focusing on the 48-h measurements, we are able to avoid placing significant emphasis on patients with transient cardiovascular, respiratory or renal dysfunction and focus on those who have a more sustained postoperative severity of illness, which is more likely to influence outcome. Further, while the predictive ability of VVR48 was strongest for DMV and duration of vasoactive medication, VVR48 was also a robust predictor of DCT drainage and ICU and hospital length of stay in our patient population. These latter outcomes can be affected by a wide range of 'late' factors that cannot be measured or otherwise accounted for in the immediate postoperative period. For example, chylothoraces can develop following the initiation of enteral feedings, resulting in prolongation of chest tube drainage. Perhaps more commonly, non-cardiac comorbidities (e.g. feeding difficulties), social issues (e.g. parent teaching) and hospital logistics (e.g. bed availability) are responsible for increasing ICU and hospital length of stay. Hence, the significant relationships observed between VVR48 and DCT drainage, ICU stay and hospital stay, which occurred despite the presence of the aforementioned unpredictable factors in several patients, in particular, underscores the potential of VVR48 as a disease severity index for these children.
With regard to the outcome measures used in this study, we opted against using other outcome measures that have been the focus of other reports in this patient population such as the need for ECMO, need for renal replacement therapy or composite measures of poor outcomes that incorporate the need for these modalities and mortality. Thresholds for initiating these invasive modalities are highly variable and dependent on availability, centre experience and physician preference. By focusing on measures such as durations of mechanical ventilation, chest tube drainage, vasoactive medications and length of stay, and then defining a patient with a bad outcome as one within the upper 25%, our results may be more generalizable to other centres. Accordingly, VVR48 is readily available to clinicians caring for these patients by using traditional bedside data, unlike measurements that are centre-dependent (e.g. mixed venous oxygen saturation, left atrial blood gases) or newer experimental biomarkers that have also been studied as predictors of postoperative outcomes [18] . VVR48 can also be easily calculated, in contrast to other disease severity indices such as the paediatric logistic organ dysfunction score, paediatric risk of mortality III score and paediatric index of mortality 2 score [19] [20] [21] .
There are several practical clinical and academic applications to VVR48. This disease severity index could provide clinicians with an objective means to assess prognosis and estimate the duration of postoperative course, which is often of foremost concern to patients' families. In addition, VVR48 could allow for better patient stratification or statistical adjustment of underlying disease severity in clinical research studies devoted to this patient population. Owing to the ease by which it is calculated and thus its ability to be quickly updated in response to changing clinical status, we also anticipate that, with further study, a daily VVR could prove to have utility akin to the sequential organ failure assessment (SOFA) score. The SOFA score has become popular as a validated means to quantify and track the disease burden in critically ill adult patients, including those recovering from cardiac surgery [22, 23] . Yet, to our knowledge, no such score has been validated in paediatric patient populations. Finally, though we did not assess the ability of VVR48 as a predictor of the need for postoperative ECMO or postoperative mortality, the markedly elevated VVR48 values noted in the 3 patients who expired demonstrate the potential for VVR48 to predict these most undesirable outcomes and should be the focus of study in a much larger multicentre cohort of patients.
There are some limitations in this study that should be noted. Our study was a pilot study devoted to acyanotic neonates and infants, and thus cannot yet be generalized to patients with mixing lesions or older children undergoing surgery for congenital heart disease. To address this important limitation, the follow-up studies including these patient populations are currently underway at our institution. These studies are practicable, given that oxygenation is not a component of VVR48 and, thus, when completed, will hopefully extend the practical utility of this index. Additionally, since our study was a pilot study performed without fixed a priori cut-off points with regard to VVR48, our model does have the risk of over-fitting the data. Confirmatory studies using independent datasets are now needed before VVR48 is incorporated into bedside practice or clinical research. VVR48 is also limited in that it cannot reliably be calculated for patients requiring ECMO support at 48 h postoperatively, though the need for ECMO in these patients, in and of itself, is an important marker of disease severity. Our study only included on admission, peak and 48 h measurements, which have been the focus of prior reports [7] [8] [9] . Future studies should also focus on VVR measurements at other specified time points such as 12 and 24 h postoperatively, as measurements made earlier in a patient's postoperative course could be even more helpful to the bedside clinician. Finally, the VVR is affected by limitations previously noted in the VIS [8] -it does not assess the importance of its individual components, and vasoactive medication administration and ventilator support that is not strictly protocolized may be affected by variation in physician practice. In most cases, however, patients who receive generous amounts of vasoactive and ventilator support do so because that support is clinically indicated by the degree of their cardiopulmonary dysfunction. The components of the VVR should therefore be reasonable surrogates for postoperative illness severity.
CONCLUSIONS
We have demonstrated that the novel VVR score after cardiac surgery has the potential to be a powerful means of predicting postoperative outcomes such as length of mechanical ventilation, vasoactive and inotropic medications, DCT drainage, and ICU and hospital stay. This score could address an important need in contemporary paediatric ICU care: a robust and easily calculated severity of illness score that predicts outcomes after surgery for congenital heart disease.
